Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;9(7):592.
doi: 10.21037/atm-20-2280.

Fugitive aerosols in the intensive care unit: a narrative review

Affiliations
Review

Fugitive aerosols in the intensive care unit: a narrative review

Ciarraí O'Toole et al. Ann Transl Med. 2021 Apr.

Abstract

The risk of unintended inhalation of fugitive aerosols is becoming a topic of increasing interest in the healthcare arena. These fugitive aerosols may be bioaerosols, generated by the patient themselves through cough or sneeze, or they may be therapeutic medical aerosols, generated by therapeutic medical aerosol generators with the intent of delivery to a specific patient's respiratory tract. This review focus' on therapeutic aerosols in the intensive care unit (ICU) only, those typically generated by nebulisers. In the intensive care environment, patients are generally in receipt of ventilatory support, and the literature suggests that these different support interventions influence fugitive therapeutic medical aerosol emissions in a variety of ways. Predominant ventilatory support interventions include, but are not limited to, invasive mechanical ventilation (MV), non-invasive mechanical ventilation (NIV), high flow nasal therapy (HFNT), and supplemental oxygen delivery in spontaneously breathing patients. Further, factors such as nebuliser type, patient interface, patient breathing pattern, nebuliser position in the patient breathing circuit and medication formulation characteristics also have been shown to exert influence on aerosol concentrations and distance from the source. Here we present the state of the art knowledge in this, as yet, poorly described field of research, and identify the key risks, and subsequently, opportunities to mitigate the risks of unintended exposure of both patients and bystanders during and for periods following the administration of therapeutic aerosols.

Keywords: Aerosols; exposure; fugitive; intensive care unit (ICU); jet nebulizer (JN); secondary inhalation; vibrating mesh nebuliser (VMN).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-2280). The series “Medical Aerosol in Acute and Critical Care” was commissioned by the editorial office without any funding or sponsorship. CO, JAM, and MAB reports grants from Irish Research Council, during the conduct of the study. MJ, AO, and RM reports personal fees from Aerogen Limited, outside the submitted work. The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Nebuliser systems, their components and the features facilitating the potential for fugitive aerosol (A) VMN plus valved facemask (B) VMN plus mouthpiece (C) JN plus open facemask (D) JN plus mouthpiece. VMN, Vibrating Mesh Nebuliser. JN, Jet Nebuliser. [Adapted with permission (28)].
Figure 2
Figure 2
Non-invasive ventilation system and components, and the features facilitating the potential for fugitive aerosol. (A) High flow nasal cannula; (B) nonvasive facemask; (C) ventilation hood. [Adapted with permission (28)].
Figure 3
Figure 3
Invasive mechanical ventilation system and components, and the features facilitating the potential for fugitive aerosol.

References

    1. Frank E, Ishau S, Maier A, et al. An occupational exposure limit (OEL) approach to protect home healthcare workers exposed to common nebulized drugs. Regul Toxicol Pharmacol 2019;106:251-61. 10.1016/j.yrtph.2019.04.021 - DOI - PubMed
    1. Beach JR, Campbell M, Andrews DJ. Exposure of health care workers to pentamidine isethionate. Occup Med (Lond) 1999;49:243-5. 10.1093/occmed/49.4.243 - DOI - PubMed
    1. Dimich-Ward H, Wymer ML, Chan-Yeung M. Respiratory Health Survey of Respiratory Therapists. Chest 2004;126:1048-53. 10.1378/chest.126.4.1048 - DOI - PubMed
    1. Mapp CE, Boschetto P, Maestrelli P, et al. Occupational Asthma. Am J Respir Crit Care Med 2005;172:280-305. 10.1164/rccm.200311-1575SO - DOI - PubMed
    1. Kern DG, Frumkin H. ASTHMA IN RESPIRATORY THERAPISTS. Annals of Internal Medicine 1989;110:767-73. 10.7326/0003-4819-110-10-767 - DOI - PubMed

LinkOut - more resources